acetazolamide has been researched along with Carbohydrate-Deficient Glycoprotein Syndrome in 1 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| " AZATAX was designed to establish whether acetazolamide is safe and improves cerebellar syndrome in PMM2-CDG." | 2.90 | AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). ( Arango, P; Artuch, R; Bolasell, M; Callejón-Póo, L; Casas-Alba, D; Corral, J; Cuadras, D; de la Morena, E; Freniche, V; Gassiot, S; Itzep, DC; Jaeken, J; Martínez-Monseny, AF; Montero, R; Pérez, B; Pérez-Cerdá, C; Serrano, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martínez-Monseny, AF | 1 |
| Bolasell, M | 1 |
| Callejón-Póo, L | 1 |
| Cuadras, D | 1 |
| Freniche, V | 1 |
| Itzep, DC | 1 |
| Gassiot, S | 1 |
| Arango, P | 1 |
| Casas-Alba, D | 1 |
| de la Morena, E | 1 |
| Corral, J | 1 |
| Montero, R | 1 |
| Pérez-Cerdá, C | 1 |
| Pérez, B | 1 |
| Artuch, R | 1 |
| Jaeken, J | 1 |
| Serrano, M | 1 |
1 trial available for acetazolamide and Carbohydrate-Deficient Glycoprotein Syndrome
| Article | Year |
|---|---|
AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Cerebellar Diseases; Child; Child, Prescho | 2019 |